Amway India has announced a few updates on its business continuity plans, while also talking about a few trends it noticed in the market recently. As its manufacturing plants start operating, it is expecting to get back to its business soon.
It said it is expecting its business to come back toÂ at least 80-90% of pre-lockdown levels byÂ July end, as expects online sales (website) to continue to contribute 80-85% to the overall sales.
As part of ensuring business continuity and in line with the new relaxation guidelines announced by the Government, the company is ensuring that its staff follows all the mandatory hygiene guidelines as its warehouses, manufacturing plant and locational stores are operational.
As it is placed to address the evolving consumer demands in the marketing in real-time, the company has witnessed a couple of trends.
Covid-19 has augmented the demand for immunity enhancing products, home disinfectants and personal hygiene essentials. The company is witnessing a surge in demand for its immunity boosting and hygiene products and have aligned all supply chain actions to fulfil these requirements.
To meet the immediateÂ consumer need and demand, in the last few months, it introduced a unique productÂ PersonaÂ Hand Sanitizer Gel and supplied a total of 4.5l unitsÂ within a span of 30 days. Currently, it is also assessing the supply of immunity boosting products to potential markets globally.
It stated, â€œWe have observed aÂ spike in the sale of immunity supporting SKUs by almost three times, including the herbal range supporting immunity and respiratory health.
Some of the products includeÂ Nutrilite Tulsi, Nutrilite Natural C, Pursue Disinfectant, Persona Soap, among others.
It also has seen a pre-empting rise in demand of immunity and hygiene products, and therefore it is gearing upÂ to ramp up production of these SKUs by four times in the coming months and maintain the product availability to 95%.
The company is working round-the-clock with its supply chain partners and distribution teams and also expedited supplies of raw material and components, from both local as well as global sources, to ensure consistent product supply.
It has also enhanced manufacturing capacity at contract partners to ensure adequate supply. With these initiatives, it has been able to maintainÂ high product availability of 98%Â through the health crisis.